Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers
Status: | Completed |
---|---|
Conditions: | Anxiety, Lung Cancer, Cancer, Cancer |
Therapuetic Areas: | Oncology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | Any |
Updated: | 5/5/2014 |
Start Date: | November 2012 |
End Date: | June 2014 |
Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in
patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral
therapy may reduce anxiety and improve the well-being and quality of life of patients who
have stage IV non-small cell lung cancer and their caregivers.
patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral
therapy may reduce anxiety and improve the well-being and quality of life of patients who
have stage IV non-small cell lung cancer and their caregivers.
PRIMARY OBJECTIVES:
I. To identify, through both quantitative and qualitative methods, clinical correlates of
anxiety and points of intervention to reduce anxiety in patients with late-stage lung cancer
and their primary caregivers.
II. To apply these findings to develop a brief dyadic intervention based on Cognitive
Behavioral Therapy (CBT) to reduce anxiety in late-stage lung cancer patients and their
primary caregivers.
III. To evaluate the feasibility and acceptability of the pilot intervention through number
of completed visits and assessment pre- and post- intervention.
OUTLINE:
Participants undergo cognitive behavioral therapy over 1 hour once weekly for a total of 6
sessions. Sessions are tailored to patient and caregiver cognitions and approach and
avoidance behaviors.
After completion of study treatment, participants are followed up at 1 week.
I. To identify, through both quantitative and qualitative methods, clinical correlates of
anxiety and points of intervention to reduce anxiety in patients with late-stage lung cancer
and their primary caregivers.
II. To apply these findings to develop a brief dyadic intervention based on Cognitive
Behavioral Therapy (CBT) to reduce anxiety in late-stage lung cancer patients and their
primary caregivers.
III. To evaluate the feasibility and acceptability of the pilot intervention through number
of completed visits and assessment pre- and post- intervention.
OUTLINE:
Participants undergo cognitive behavioral therapy over 1 hour once weekly for a total of 6
sessions. Sessions are tailored to patient and caregiver cognitions and approach and
avoidance behaviors.
After completion of study treatment, participants are followed up at 1 week.
Inclusion Criteria:
- Diagnosis of stage IV non-small cell lung cancer
- At least 6 weeks post-diagnosis
- Current symptoms of anxiety (e.g., Hamilton Rating Scale for Anxiety [HAM-A] >=14)
- Ability to understand and the willingness to sign a written informed consent document
- CAREGIVER: Identified by patient as primary caregiver
- CAREGIVER: At least 14 hours/week spent caring for patient
- CAREGIVER: Current symptoms of anxiety (e.g., HAM-A >= 14)
- CAREGIVER: Ability to understand and the willingness to sign a written informed
consent document
Exclusion Criteria:
- PATIENTS AND CAREGIVERS:
- Active, unstable, untreated serious mental illness
- Other cognitive inability to complete informed consent process or study procedures
We found this trial at
1
site
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
Click here to add this to my saved trials